kneat.com (CVE:KSI) and Burcon NutraScience (TSE:BU) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
Valuation and Earnings
This table compares kneat.com and Burcon NutraScience's top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
kneat.com | C$7.42 million | 27.52 | C$-5,797,862.00 | C($0.09) | -35.23 |
Burcon NutraScience | C$12,045.00 | 35,744.79 | C$107,101.00 | C$0.00 | 4,020.00 |
Burcon NutraScience has lower revenue, but higher earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Burcon NutraScience, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares kneat.com and Burcon NutraScience's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
kneat.com | N/A | N/A | N/A |
Burcon NutraScience | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of recent recommendations for kneat.com and Burcon NutraScience, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
kneat.com | 0 | 0 | 1 | 0 | 3.00 |
Burcon NutraScience | 0 | 0 | 1 | 0 | 3.00 |
kneat.com currently has a consensus target price of C$2.75, suggesting a potential downside of 9.24%. Burcon NutraScience has a consensus target price of C$5.00, suggesting a potential upside of 24.38%. Given Burcon NutraScience's higher probable upside, analysts clearly believe Burcon NutraScience is more favorable than kneat.com.
Summary
Burcon NutraScience beats kneat.com on 5 of the 6 factors compared between the two stocks.